Amarin Announces Results of Annual General Meeting of Shareholders
DUBLIN, Ireland and BRIDGEWATER, N.J., April 22, 2024 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN) today announced shareholder approval of […]
Fresh2 Group Ltd. Announces Receipt of a Delinquency Compliance Alert Notice from Nasdaq
New York, NY, April 22, 2024 (GLOBE NEWSWIRE) — Fresh2 Group Ltd. (NASDAQ: FRES) (“Fresh2” or the “Company”), a B2B […]
INmune Bio Inc. Raises Approximately $4.8 Million in Gross Proceeds Through Registered Direct Offering with Officers, Employees and Directors Purchasing Approximately 20% of the Offering
Boca Raton, Florida, April 22, 2024 (GLOBE NEWSWIRE) — INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused […]
DLH to Announce Fiscal 2024 Second Quarter Financial Results
ATLANTA, April 22, 2024 (GLOBE NEWSWIRE) — DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading healthcare and […]
VERB’s MARKET.live Adds Another 100 Retail Brands to Its Livestream Social Shopping Platform
LOS ALAMITOS, Calif. and LAS VEGAS, April 22, 2024 (GLOBE NEWSWIRE) — Verb Technology Company, Inc. (Nasdaq: VERB) (“VERB” or […]
ELEVAI Labs Enters the Taiwan Market with Signing of 5th International Distribution Agreement in 14 Months
Taiwan is ELEVAI’s third Asian contract for exosomes distribution after adding the Philippines in August of 2023 and Vietnam in […]
Catalyst Pharmaceuticals to Report First Quarter 2024 Financial Results on May 8, 2024
CORAL GABLES, Fla., April 22, 2024 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company […]
DZS Appoints Brian Chesnut as Chief Accounting Officer
DALLAS, April 22, 2024 (GLOBE NEWSWIRE) — DZS (Nasdaq: DZSI), a global leader of broadband networking and AI-driven cloud software […]
Synchronoss Technologies Announces First Quarter 2024 Earnings Call Date and Participation in Upcoming Investor Events
BRIDGEWATER, N.J., April 22, 2024 (GLOBE NEWSWIRE) — Synchronoss Technologies, Inc. (“Synchronoss” or the “Company”) (Nasdaq: SNCR), a leading global […]
Celularity Inc. to Host Investor and Analyst Research & Development Day
FLORHAM PARK, N.J., April 22, 2024 (GLOBE NEWSWIRE) — Celularity Inc. (NASDAQ: CELU) (“Celularity”), a regenerative and cellular medicine company developing [...]
